Turn Therapeutics Inc. Common Stock financial statements

턴 테라퓨틱스NASDAQ:TTRX · Nasdaq
$12.10+3.95%
2026-10-07 close

Turn Therapeutics Inc. Common Stock's published financial data is dated 2026-10-04. The display ticker is TTRX. The trading market is Nasdaq.

Reported results

Financial safety

Reference indicatorAs of 2024
Distress zoneFinancial-metric reference signal
Altman Z'' zoneZ'' -29.38
Distress
Grey
Safe
The marker shows the current Z'' value within the displayed zones.
Altman Z''
-29.38
Beneish M-Score
—

Statistical flag unavailable

Sloan accrual
-19.87%

부실·조작 위험을 나타내는 사실 지표입니다. 투자 조언이 아니며, 검증 전이라 참고용입니다.

Factual information, not investment advice.

Earnings quality · Piotroski F-Score

3/9Weak

Piotroski measures year-over-year financial improvement, not absolute quality.

Financial improvement score3/9

Profitability

  • Positive ROANot passed
  • Positive OCFNot passed
  • Improving ΔROAPass
  • Accruals (OCF > net income)Pass

Leverage & liquidity

  • Lower debtNot passed
  • Higher current ratioPass
  • No new sharesNot passed

Efficiency

  • Higher gross marginNot passed
  • Higher asset turnoverNot passed

Calculation note: F7(신주)은 equity/asset 유지로 근사

Already-stable companies may score lower when year-over-year improvement is limited.

Factual information, not investment advice.

Forensic signals

Anomaly and structural signals observed in the financial statements.

Balance sheetDanger

자본잠식 — 자본총계가 마이너스입니다. 부실 위험을 나타내는 사실 지표입니다.

Factual information, not investment advice.

Turn Therapeutics Inc. Common Stock notifications

Quantus Signal · live data · not investment advice · Privacy Policy